Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19.

Xiaowei GongShiwei KangXianfeng GuoYan LiHaixiang GaoYa-Dong Yuan

Published in: BMC infectious diseases (2021)

Age > 60 years, D-dimer > 0.243 μg/ml, and lower oxygenation index were associated with severe COVID-19. Arbidol might provide more clinical benefits in treating patients with severe COVID-19 compared with ribavirin.

Keyphrases

coronavirus disease
sars cov
early onset
drug induced
emergency department
blood flow
mesenchymal stem cells
replacement therapy